Indraprastha Medical Corporation Management Change
Mr. Shivakumar Pattabhiraman has completed his two-year tenure as Managing Director of Indraprastha Medical Corporation Ltd. He ceased to hold the position effective November 4, 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
Mr. Shivakumar Pattabhiraman has completed his two-year tenure as Managing Director of Indraprastha Medical Corporation Ltd. He ceased to hold the position effective November 4, 2026.
Indraprastha Medical reported Q2FY27 revenue from operations of Rs 412.85 crore and PAT of Rs 53.58 crore. Half-year PAT rose to Rs 109.43 crore from Rs 100.92 crore a year earlier.
Indraprastha Medical Corporation will hold a board meeting on 29 Oct 2026 to consider Q1 FY27 unaudited standalone financial results. The trading window is closed from 1 Oct to 31 Oct 2026.
The Company has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Indraprastha Medical Corporation Ltd announced voting results for its AGM held on September 24, 2026. Shareholders approved a dividend of Rs. 4.00 per equity share.
Indraprastha Medical Corporation Limited held its 38th AGM on September 24, 2026. Shareholders considered resolutions including a Rs. 4.00 per share dividend declaration.